Lipid Nanoparticle (LNP) Generator System Supply

The contract requires the supply of a complete benchtop Lipid Nanoparticle Generator System designed for the reproducible, small-scale synthesis of lipid nanoparticles to encapsulate therapeutic agents including mRNA, DNA, siRNA, proteins, and small molecules. This system is intended to support preclinical therapeutic development and facilitate the preparation of data for Investigational New Drug (IND) applications. The equipment must deliver consistent, high-quality LNPs with precise control over parameters critical to efficacy and safety, ensuring compatibility with regulatory standards for advanced therapy products. The solicitation is classified as a subcontract under NAICS code 333318 and is issued by the National Institutes of Health under the Department of Health and Human Services. The opportunity was posted on June 30, 2026, with a firm response deadline of July 22, 2026, at 4:00 PM. No specific place of performance or point of contact is provided in the data, and no set-aside designation is indicated. Bidders must ensure the delivered system meets technical specifications for scalability, reliability, and compliance with preclinical manufacturing requirements without reliance on large-scale industrial infrastructure.